Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.

about

Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.

Item

http://www.wikidata.org/entity/Q45323778

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@en

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@nl

type

Item

label

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@en

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@nl

prefLabel

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@en

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@nl

P1476

Key Factors Influencing the Em ...... - and Middle-Income Countries.

@en

P2093

Carole L Wallis

http://www.w3.org/2001/XMLSchema#string

Catherine Godfrey

http://www.w3.org/2001/XMLSchema#string

John W Mellors

http://www.w3.org/2001/XMLSchema#string

Joseph E Fitzgibbon

http://www.w3.org/2001/XMLSchema#string

P2860

The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing

A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism

High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa

Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settings.

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

P304

S851-S856

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1093/INFDIS/JIX409

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

suppl_9

http://www.w3.org/2001/XMLSchema#string

P478

216

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207000

http://www.w3.org/2001/XMLSchema#string

P932

5853971

http://www.w3.org/2001/XMLSchema#string